This approach involves a single guide RNA (sgRNA) that guides the Cas9 nuclease to cleave the targeted HuR DNA, inducing double-stranded breaks (DSBs) at specific genomic loci to diminish HuR’s functions in BC progression. Here, ELAVL1 is linked to breast cancer.